Form 4: Outset Medical SVP Operations and R&D Sells Shares to Cover Tax Obligations

Marc Nash, SVP of Operations and R&D at Outset Medical, sold 15,011 shares of common stock to cover tax obligations related to vesting RSUs.

Summary

• Marc Nash, the Senior Vice President of Operations and R&D at Outset Medical, sold 15,011 shares of the company's common stock on January 13, 2025.
• The sale was executed at a price of $0.81 per share.
• This transaction was not a discretionary trade but rather a 'sell to cover' transaction to satisfy tax withholding obligations.
• The tax obligations arose from the vesting of 31,996 shares of common stock underlying Restricted Stock Units (RSUs) granted to Mr. Nash on January 12, 2024.
• Following the transaction, Mr. Nash directly owns 222,291 shares of Outset Medical common stock.

Sentiment

Score: 5

Explanation: The document reflects a routine transaction related to executive compensation and does not indicate any positive or negative sentiment about the company's performance.

Management Comments

• The sale was made to satisfy tax withholding obligations through a 'sell to cover' transaction and does not represent a discretionary trade by the reporting person.

Industry Context

This is a routine transaction for executives who receive equity compensation. It is common for executives to sell shares to cover tax obligations when RSUs vest.

Comparison to Industry Standards

• Similar transactions are common across publicly traded companies where executives receive stock-based compensation.
• The 'sell to cover' mechanism is a standard practice to manage tax liabilities associated with vesting equity.

Stakeholder Impact

• The transaction has a minimal impact on shareholders as it is a routine sale to cover tax obligations.

Key Dates

Keywords

Outset Medical, stock sale, insider trading, Form 4, RSU, tax obligations, equity compensation, Marc Nash